GNLKQ (Genelink) Other Current Liabilities: $0.01 Mil (As of Sep. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Genelink Other Current Liabilities?

Genelink GNLKQ Other Current Liabilities is $0.01 Mil as of Sep. 2013.

Genelink's other current liabilities for the quarter that ended in Sep. 2013 was $0.01 Mil.

Genelink's quarterly other current liabilities increased from Mar. 2013 ($0.01 Mil) to Jun. 2013 ($0.03 Mil) but then declined from Jun. 2013 ($0.03 Mil) to Sep. 2013 ($0.01 Mil).

Genelink's annual other current liabilities increased from Dec. 2010 ($0.21 Mil) to Dec. 2011 ($0.30 Mil) but then declined from Dec. 2011 ($0.30 Mil) to Dec. 2012 ($0.03 Mil).

Genelink Other Current Liabilities Related Terms

Genelink Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Genelink's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genelink Other Current Liabilities Chart

Genelink Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.21 0.21 0.30 0.03

Genelink Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.01 0.03 0.01

Genelink Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.01 Mil mean?
Genelink (GNLKQ) has a Other Current Liabilities of $0.01 Mil as of Sep. 2013. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Genelink.
Is Genelink's Other Current Liabilities too high?
Genelink's current Other Current Liabilities is $0.01 Mil.
How does Genelink's Other Current Liabilities compare to VITIF and HSTC?
Genelink's Other Current Liabilities of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Genelink. Genelink's current Other Current Liabilities is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelink stock overvalued right now?
Genelink (GNLKQ) has a current Other Current Liabilities of $0.01 Mil. The current Other Current Liabilities is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Genelink (GNLKQ), the current Other Current Liabilities is $0.01 Mil as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genelink Business Description

Address 8250 Exchange Drive, Suite 120, Orlando, FL, USA, 32809
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.